» Articles » PMID: 36874025

Crebanine Induces ROS-dependent Apoptosis in Human Hepatocellular Carcinoma Cells the AKT/FoxO3a Signaling Pathway

Overview
Journal Front Pharmacol
Date 2023 Mar 6
PMID 36874025
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC), as an aggressive cancer with a high mortality rate, needs high-efficiency and low-toxicity drug therapy. Natural products have great potential as candidate lead compounds for the development of new HCC drugs. Crebanine is an isoquinoline alkaloid derived from Stephania with various potential pharmacological effects such as anti-cancer. However, the molecular mechanism underlying crebanine-induced liver cancer cells apoptosis has not been reported. Here, we investigated the effect of crebanine on HCC and identified a potential mechanism of action. In this paper, we intend to detect the toxic effects of crebanine on hepatocellular carcinoma HepG2 cells through a series of experiments, including detecting the effects of crebanine on the proliferation of HepG2 cells using the CCK8 method and plate cloning assay, observing the growth status and morphological changes of crebanine on HepG2 cells by inverted microscopy; and using the Transwell method to determine the the effect of crebanine on the migration and invasion ability of HepG2 cells; using Hoechst 33258 assay to stain cancer cells, thus observing the effect of crebanine on the morphology of HepG2 apoptotic cells, and detecting the apoptotic state and level of HepG2 cells by flow cytometry; using ROS kit and JC-1 assay kit to detect the changes of reactive oxygen species and mitochondrial membrane potential of HepG2 The immunofluorescence assay was taken to verify whether crebanine had an effect on the expression of p-FoxO3a in cancer cells; the Wetern blot assay was also used to examine the effect of crebanine on proteins related to the mitochondrial apoptotic pathway and its effect on the regulation of the relative protein expression of AKT/FoxO3a axis; after this, NAC and AKT inhibitor LY294002 were used to cells were pretreated with NAC and AKT inhibitor LY294002, respectively, in order to further validate the inhibitory effect of crebanine. It was shown that crebanine effectively inhibited the growth and capacity of HepG2 cells migration and invasion in a dose-dependent manner. Furthermore, the effect of crebanine on the morphology of HepG2 cells was observed through microscopy. Meanwhile, crebanine induced apoptosis by causing reactive oxygen species (ROS) burst and mitochondrial membrane potential (MMP) disrupt. We found that crebanine could down-regulate Bcl-2 and up-regulate Bax, cleaved-PARP, cleaved-caspase-3 and cleaved-caspase-9, but these effects were overturned by ROS inhibitor N-acetylcysteine (NAC). Crebanine also down-regulated p-AKT and p-FoxO3a, and the PI3K inhibitor LY294002 significantly enhances this effect. We also found that the expression of AKT/FoxO3a signaling pathway was ROS-dependent. As shown by Western blots, NAC could partially attenuate the inhibitory effect of crebanine on AKT and FoxO3a phosphorylation. Based on our results, our results suggest that crebanine, as a compound with potential anticancer activity, has significant cytotoxic effects on hepatocellular carcinoma,and it likely induces apoptosis ROS in the mitochondrial pathway and simultaneously affects the biological function of HCC the ROS-AKT-FoxO3a signaling axis.

Citing Articles

Transcriptome Analysis of and Functional Validation of CYP80s Involved in Benzylisoquinoline Alkaloid Biosynthesis.

Shi W, Li Q, Li X, Luo L, Gan J, Ma Y Molecules. 2025; 30(2).

PMID: 39860129 PMC: 11767795. DOI: 10.3390/molecules30020259.


Crebanine mitigates glucocorticoid-induced osteonecrosis of the femoral head by restoring bone remodelling homeostasis via attenuating oxidative stress.

Dong S, Ge J, Meng Q, Yuan T, Wang Y, Li Y J Cell Mol Med. 2024; 28(16):e70044.

PMID: 39205463 PMC: 11358393. DOI: 10.1111/jcmm.70044.


Crebanine, an aporphine alkaloid, induces cancer cell apoptosis through PI3K-Akt pathway in glioblastoma multiforme.

Yeh P, Liu C, Yu C, Chang Y, Lin S, Li Y Front Pharmacol. 2024; 15:1419044.

PMID: 38895635 PMC: 11184677. DOI: 10.3389/fphar.2024.1419044.

References
1.
Huang H, Tindall D . Dynamic FoxO transcription factors. J Cell Sci. 2007; 120(Pt 15):2479-87. DOI: 10.1242/jcs.001222. View

2.
Patra T, Meyer K, Ray R, Kanda T, Ray R . Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells. Cell Death Dis. 2021; 12(11):1073. PMC: 8580964. DOI: 10.1038/s41419-021-04371-7. View

3.
Chiu H, Tay E, Ong D, Taneja R . Mitochondrial Dysfunction at the Center of Cancer Therapy. Antioxid Redox Signal. 2019; 32(5):309-330. DOI: 10.1089/ars.2019.7898. View

4.
Habrowska-Gorczynska D, Koziel M, Kowalska K, Piastowska-Ciesielska A . FOXO3a and Its Regulators in Prostate Cancer. Int J Mol Sci. 2021; 22(22). PMC: 8625444. DOI: 10.3390/ijms222212530. View

5.
Xiao-Shan H, Qing L, Yun-Shu M, Ze-Pu Y . Crebanine inhibits voltage-dependent Na+ current in guinea-pig ventricular myocytes. Chin J Nat Med. 2014; 12(1):20-3. DOI: 10.1016/S1875-5364(14)60004-2. View